Transgene Biotek Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2025 ,inter alia, to consider and approve 1) To consider and approve the Un-Audited Financial Results (Standalone & Consolidated) of the Company for the quarter ended June 30, 2025.2) To consider and approve the Extension of Annual General Meeting (AGM) of Company for financial year 2024-25.3) To consider and approve the appointment of Geeta Serwani & Associates, Company Secretary as secretarial Auditor of the Company.4) To consider and approve the internal auditor of the Company for financial year 2024-25.5) To transact such other business as may be required.